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Introduction: Mild cognitive impairment (MCI) not only negatively impacts upon a
person’s life, but it is also seen as an intermediate stage on the progression to
Alzheimer’s Disease (AD), and therefore warrants early intervention. However, there is
currently no effective pharmacological treatment approved for MCI. There is a paucity of
evidence that non-pharmacological interventions such as cognitive training could result
in improvements in the daily activities functioning of persons with MCI. Growing evidence
has shown that mindfulness meditation increases gray matter volume and concentration
in brain regions such as the hippocampus and prefrontal cortex, strengthens brain
functional connectivity, and enhances psychological well-being which could be beneficial
to counteract the memory and cognitive decline of MCI.
Aims: We aim to quantitatively investigate whether mindfulness practice can improve the
cognitive function, psychological health, mindfulness and functional abilities in activities
of daily living of the MCI participants over time; the relationship between the amount
of mindfulness practice and degree of improvement in these health outcomes; and the
differential effects and interactions of both formal and informal mindfulness practices. We
will also qualitatively address the issues about the MCI participants’ and familiar support
persons’ engagement with the program, the nature of group interactions, their program
experience, their perceived effects and expectations of mindfulness practice, and the
challenges encountered in practicing mindfulness.
Methods: Our study is one of the first mixed-methods longitudinal studies with a 1-year
follow-up using a pre- and post-intervention design. It involves the MCI participants
and their familiar support person in a customized 8-week group-based mindfulness
training program. The outcome measures will use the Montreal Cognitive Assessment,
Depression Anxiety Stress Scales, Freiburg Mindfulness Inventory and Bayer Activities of
Daily Living Scale. The qualitative methods will include participant observation during the
program and semi-structured interviews at post-intervention and 1-year follow-up.
Significance: This customized MCI group mindfulness training program presents
as a promising and feasible non-pharmacological therapeutic intervention option for
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MCI and a possible preventive strategy for Alzheimer’s disease. This study has
been registered in the Australian New Zealand Clinical Trials Registry (ANZCTR)
(URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366695) and
allocated the ACTRN: ACTRN12614000820606.
Keywords: mindfulness, meditation, mild cognitive impairment, mild neurocognitive disorder, cognitive function,
psychological health, functional abilities, activities of daily living
INTRODUCTION
According to theWorld Health Organization, 47.5 million people
worldwide have dementia with an annual incidence of 7.7 million
new cases every year. This number is projected to increase to
75.6 million people by 2030 and to 135.5 million people by
2050 (WHO, 2016). Notwithstanding the impact of dementia
on the families and caregivers of persons with dementia, the
economic burden of dementia was estimated to be US$604 billion
in 2010, equivalent to 1% of the worldwide gross domestic
product (WHO, 2016). Although dementia is not a natural
phase of normal aging, the majority of people with dementia
are older people (AIHW, 2015). It has been estimated to be the
developed world’s third largest burden of disease after depression
and ischemic heart disease by the year 2030 (Mathers and Loncar,
2006).
Alzheimer’s disease (AD) is the most common form of
dementia and comprises 60–70% of cases (WHO, 2016). Mild
cognitive impairment (MCI) refers to the transitional state of
cognitive changes between normal aging and AD (Petersen
et al., 2001). The clinical and cognitive criteria for MCI evaluate
negative changes in the individual’s cognition compared to
his/her previous level. These include objective evidence of
impairment in one or more cognitive domains (Albert et al.,
2011). One of the most commonly implicated cognitive domains
is episodic memory–that is, “conscious recall of events and
verbal/visual materials, measured by the ability to recall lists of
words or recognize faces both immediately and after a delay”
(Henry et al., 2011). Preservation of independence in functional
abilities and non-diagnosis of dementia are also important for a
diagnosis for MCI (Albert et al., 2011).
Each year, approximately 10–15% of MCI patients converted
to AD, compared to the 1–2% annual conversion rate of healthy
controls (Petersen et al., 1997, 2001). The MCI sub-clinical
population is therefore possibly in “a transitional zone between
normal cognition function and clinically probable AD” (Winblad
et al., 2004), and should be identified and targeted for early
therapeutic intervention.
The risk factors for dementia are essentially the same as those
for heart disease (Chen et al., 2014). Preventive approaches are
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Bayer Activities of Daily Living; CDAMS, Cognitive, Dementia and Memory
Service; CH, Craig Hassed (author); DASS-21, 21-item Depression Anxiety Stress
Scales; DHL, Demographic, Health and Lifestyle; e.g., For example; FMI, Freiburg
Mindfulness Inventory; FSP, Familiar Support Person; GP, General Practitioner;
JC, Jan Coles (author); MAQ, Mindfulness Adherence Questionnaire; MBSR,
Mindfulness-Based Stress Reduction; MCI, Mild Cognitive Impairment; MoCA,
Montreal Cognitive Assessment; RC, Richard Chambers (author); WW, Wee Ping
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important particularly in light of the fact that while several
drugs are used for treating AD, there is currently no effective
pharmacological treatment approved for MCI. Studies on
pharmacological treatments using cholinesterase inhibitors that
are approved by the United States Food andDrug Administration
(FDA) and the Australian Therapeutic Goods Administration
(TGA), such as donepezil (Aricept R©), rivastigmine (Exelon R©)
and galantamine (Razadyne R©, Galantyl R©, Reminyl R©), on MCI
patients to provide short-term benefits for mild to moderately
severe AD, have produced mixed evidence with inconclusive
results on cognitive improvement or progression from MCI to
AD (Vega and Newhouse, 2014).
One other factor contributing to the risk of MCI and AD
is poor sleep (Tsapanou et al., 2015). Not only has this been
associated with a higher risk of AD but also poorer clearance
of beta-amyloid from the brain at night (Mander et al., 2015;
Sprecher et al., 2015). Mindfulness training has been found to
improve sleep in older adults, suggesting another possible link
between mindfulness, MCI and AD (Winbush et al., 2007; Black
et al., 2015).
Cognitive training is one of the interventions used in
the management of MCI (Henry et al., 2011). However, one
Cochrane review concluded that due to the inadequate quality
of evidence, the limited effects of performance gains derived
from cognitive interventions could not be attributed to specific
training effects as these improvements did not exceed those in
active control conditions (Martin et al., 2011). Another Cochrane
review simply found no significant gains from cognitive training
(Bahar-Fuchs et al., 2013). More importantly, the few individual
studies that found preliminary evidence of potential benefits
derived from cognitive training have not established whether the
effects were generalized to the daily functioning of persons with
MCI. In light of this, there is a need for therapeutic interventions
that specifically target risk factors that could be transferrable to
activities of daily living (ADL) for persons with MCI.
Mindfulness can be described as a way of training attention
and fostering awareness. This can be done through formal
attentional training (mindfulness meditation) or informal
practice and applications by being more attentive and engaged in
daily life. When unmindful, distracted and inattentive, the brain
switches into default mode which has been associated with poor
mental health (Brewer et al., 2011) as well as higher amyloid-beta
deposition (Simic et al., 2014). Mindfulness training has been
found to switch off default mode (Brewer et al., 2011).
Studies have also shown a positive association between
amount of meditation practice and meta-cognitive awareness
(Garland et al., 2009), attentional performance and cognitive
flexibility (Moore and Malinowski, 2009). Early intervention
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with mindfulness training is therefore a feasible and efficacious
non-pharmacological therapeutic intervention option that may
improve the cognitive function of persons with MCI and prevent
progression to AD. Indeed, there is already growing evidence
to suggest that meditation may be a potentially useful and
affordable treatment approach for enhancing cognition and
memory in patients with neurodegenerative diseases (Newberg
et al., 2014). The positive effects of meditation on cognition and
dementia risk reduction may be achieved holistically through
multiple pathways such as producing neuroprotective effects
from less stress-induced cortisol secretion with higher brain-
derived neurotrophic factor (BDNF) levels; enhancing lipid
profiles and reducing oxidative stress, thereby reducing risk
for cerebrovascular/age-related neurodegenerative diseases; and
reinforcing neuronal circuits and boosting cognitive reserve
(Xiong and Doraiswamy, 2009). Moreover, “studies have
demonstrated the effects of mindfulness on enlarging gray
matter volume (Pagnoni and Cekic, 2007; Luders et al., 2009),
increasing gray matter concentration (Hölzel et al., 2008;
Vestergaard-Poulsen et al., 2009; Hölzel et al., 2011; Singleton
et al., 2014), strengthening brain functional connectivity (Brewer
et al., 2011; Jang et al., 2011; Hasenkamp and Barsalou,
2012; Taylor et al., 2013; Wells et al., 2013b), and enhancing
psychological well-being (Singleton et al., 2014), thus suggesting
the potential benefits of mindfulness on MCI” (Wong et al.,
2015). Mindfulness can thus prevent the “tissue volume loss in
the hippocampus and posterior cingulate/precuneus (Buckner
et al., 2005; Beason-Held, 2011; Fotuhi et al., 2012; Wang et al.,
2013), gradual loss of gray matter (Thompson et al., 2003),
reduced functional connectivity in the default mode network
(Sorg et al., 2007; Gili et al., 2011; Hafkemeijer et al., 2012; Wang
et al., 2013), and high chronic psychological distress (Wilson
et al., 2007) that are all implicated in the memory and cognitive
decline observed in MCI and AD” (Wong et al., 2015).
Two small pilot clinical studies have been conducted on
persons with MCI and dementia using the Mindfulness-Based
Stress Reduction (MBSR) course. In the first study, a preliminary
assessment of the feasibility of eight 2-h weekly MBSR sessions
and one mindfulness retreat day that was conducted using a
pilot randomized trial with a small sample of 14 MCI adults,
found a non-statistically significant trend toward improvement
of cognition and well-being (Wells et al., 2013a). The second
pilot study involving 12 persons with dementia and 8 carers
again found non-statistically significant improvements in mental
well-being after attending eight 2.5-h weekly MBSR course but a
non-significant decrease in well-being between post-intervention
and 3-month follow-up. Even so, qualitative analyses from course
observations and interviews showed that some participants
with dementia were able to learn mindfulness and experienced
subjective improvements in several quality of life dimensions
(Leader et al., 2013).
A key methodological limitation in these studies may
be that the generic content of the MBSR course was not
customized to the specific needs of the participants with cognitive
impairment. There is a lack of longer-term monitoring of the
longitudinal effects of mindfulness practice on persons withMCI.
Another limitation is the failure to achieve statistical significance
because of the small sample sizes in these studies. Finally,
the main focus of the MBSR course is on formal mindfulness
practice (meditation) and may have insufficiently emphasized
the informal mindfulness practice in daily living activities, for
example (e.g.,) by incorporating informal mindfulness practice
into everyday activities and daily experiences. Such informal
mindfulness practice can be tied in with existing ADL (e.g., by
encouraging people to eat, travel and communicate mindfully) to
promote sustained mindfulness outside of meditation sessions.
It would also enhance engagement with ADL, significantly
increasing cognitive stimulation throughout the day, which could
be assumed to be beneficial for persons with MCI. There is
preliminary evidence for this, such as Landau et al.’s study which
reported increased cognitive activity such as reading, writing and
playing games particularly in early- and middle-life, may directly
reduce the beta-amyloid before the onset of AD, as shown that
older individuals with high cognitive activity had beta-amyloid
comparable to the young controls, while those with low cognitive
activity had similar beta-amyloid as the AD patients (Landau
et al., 2012).
Overall, the above studies suggest that a longitudinal study
into a mindfulness training program that incorporates both
the formal (mindfulness meditation) and informal (application
in daily living activities) practices of mindfulness, and that
is customized to the needs, health outcomes and level of
understanding of persons with MCI, is warranted. The proposed
study will meet this need.
Study Design
This study adopts a non-randomized pre-/post-intervention
design. Persons with a clinical diagnosis of MCI from
treating health professionals will receive an 8-week group-based
mindfulness training program which is customized to their
needs, health outcomes and level of understanding. A follow-up
assessment will be conducted one year after the program
completion to measure the longitudinal effects of mindfulness
practice on persons with MCI over time.
Research Questions
Our hypotheses are:
a. That mindfulness practice will improve the cognitive function,
psychological health, mindfulness and ADL functioning of
persons with MCI.
b. The degree of these improvements in cognitive function,
psychological health, mindfulness and ADL functioning will
correlate positively with the amount of mindfulness practice.
To test these hypotheses, the following quantitative research
questions were formulated:
a. Does mindfulness practice improve the cognitive function,
psychological health, mindfulness and ADL functioning of
persons with MCI?
b. Does the degree of improvement in cognitive function,
psychological health, mindfulness and ADL functioning vary
with the amount of mindfulness practice?
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c. How much of any observed improvement is due to formal
mindfulness practice and how much is due to informal
applications of mindfulness to ADL?
Further, this study aims to address the following qualitative
research questions:
a. How do the MCI participants and familiar support persons
(FSPs) engage with the mindfulness training program?
b. What is the nature of group interactions between the
Mindfulness Trainer and the MCI participants/FSPs and
amongst the MCI participants/FSPs during the program?
c. What is the mindfulness training program experience for the
MCI participants and FSPs (e.g. was it enjoyable, satisfactory,
stimulating and useful)?
d. What perceived effects do the mindfulness training program
and mindfulness practice generally have on the health and life
of MCI participants and FSPs?
e. What are the challenges faced by MCI participants in
implementing and maintaining mindfulness practice?
f. Do the expectations of the MCI participant and his/her FSPs
about mindfulness practice match with each other?
Study Eligibility Criteria
To participate in this study, the MCI participants must fulfil the
following inclusion criteria:
a. Clinical diagnosis of MCI;
b. Must be able to give informed consent to participate by signing
the Consent Form; and
c. At least 60 years old.
The clinical diagnosis and minimum age requirement fit the
target sample of participants that this study is investigating
on the premise that they must possess the capacity to receive
information about their involvement in this study, to consent to
the research and to participate in it.
Participants will be excluded based on the following criteria:
a. Current active or past significant experience with meditation
or yoga;
b. Current use of prescribed cognitive intervention or
electromagnetic stimulation;
c. Acquired/Traumatic brain injury;
d. Started new neurological/psychoactive medication within 3
months prior to the first data collection session;
e. Current intake of drugs that significantly alter cognition;
f. Illicit drug or alcohol abuse or dependence (more than 2
standard units of alcohol at a time and/or more than 7
standard units of alcohol in 1 week) within the previous 5
years;
g. Current intake of cholinesterase inhibitors;
h. Current severe psychiatric condition (e.g., bipolar disorder
or clinical depression); or neurological/cerebrovascular
condition; or chronic medical condition (e.g., advanced stage
of cancer, chemotherapy) that requires intensive medical
treatment and monitoring; or advanced cognitive decline;
i. Major impairments in eyesight, hearing or upper limb motor
movements; or
j. English language difficulties.
Exclusion criterion (a) of not having current active or past
significant meditation or yoga experience is relevant so as to
properly measure the effects of mindfulness on the outcome
measures. Exclusion criteria (b) to (f) are necessary to exclude
MCI participants currently using prescribed interventions;
recently started taking new neurological/psychoactive
medication or cognition-altering drugs; or who had suffered
brain injury and drug or alcohol abuse due to their possible
effects on cognition and behavior. Exclusion criterion (g)
of current intake of cholinesterase inhibitors is relevant to
screen out persons with severe cognitive impairment. Exclusion
criterion (h) is important as this study is investigating the
effects of mindfulness on persons with MCI, thus it should
not be confounded by other current severe chronic conditions.
Exclusion criteria (i) and (j) are relevant to ensure that the
MCI participants are able to participate in this study as
they will be asked to read, write, listen and speak in English
during the program and data collection sessions that include
completing cognitive assessments and questionnaires/scales, and
communicating in interviews. Information about the potential
MCI participants (contact details and relevant personal and
health information) and their FSP (name and contact details)
may be obtained from the MCI participants’ health records for
the purpose of this research.
There are no lifestyle restrictions such as physical restrictions,
sport participation or dietary restrictions imposed on the MCI
participants who may continue to take their regular prescribed
medications. However, if their medical condition, treatment or
prescribed medications change during the entire duration of
study participation, they or their FSP should inform researcher
Wee Ping Wong (WW) as soon as possible. In addition, if the
MCI participant or his/her FSP takes part in other research
studies prior to involvement in this study or intends to participate
in other research studies at any subsequent stages during this
study duration, they are requested to inform the research team
at the earliest opportunity.
Recruitment
Participation in this study is voluntary with no limitations or
conditions imposed and the MCI participants and FSPs are free
to withdraw consent from this study at any stage by informing the
research team. Their decision whether to take part or not, or to
take part and then withdraw, will not affect the MCI participants’
routine care, services, medication regimen or relationship with
their treating health professionals.
To ensure representativeness of the target population, eligible
MCI participants will be recruited within Victoria, Australia
through hospitals (including Cognitive, Dementia and Memory
Service (CDAMS), specialist clinics, General Practice clinics,
Alzheimer’s Australia and the general community in accordance
with the study eligibility criteria. Staff from the participating
CDAMS sites will brief potential MCI participants about this
study; inform them that their participation or not in the project
will not in any way affect their routine care, services, medication
regimen or relationship with treating health professionals. If the
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staff obtain verbal consent of interested persons with MCI to
provide their contact details and relevant personal and health
information, and their FSP’s contact details to the research team,
a referral form will be sent to researcher (WW). Interested
persons with MCI who respond to the study advertisement will
directly contact researcher (WW) who will brief them about this
study over the phone. In both situations, the researcher will
liaise with both the person with MCI and his/her FSP to explain
the nature of the study participation, confirm the potential
MCI participants’ study eligibility, send them the Participant
Information Sheets and Consent Forms, and arrange the first
data collection session. This provides time for them to discuss
their study participation and other parties such as General
Practitioner (GP) or treating health professional. For interested
persons with MCI who are not referred from the participating
CDAMS sites to this study, their verbal consent will be obtained
for the research team to write to their GP or treating health
professional who needs to provide their relevant personal and
health information (including theirMCI diagnosis details) so that
their study eligibility could be established.
At the first data collection session, another opportunity is
open for the potential MCI participant and FSP to ask further
questions, and seek any clarification about this study and the
nature of their involvement. Researcher (WW) will review
and discuss this study and the Participant Information Sheets
and Consent Forms with the potential MCI participant in the
presence of his/her FSP and decide whether he/she is able to:
a. Understand the nature of the research and of his/her
participation;
b. Appreciate the consequences of the participation, including
personal consequences;
c. Show the ability to consider alternatives, including the option
not to participate; and
d. show the ability to make a reasoned choice (Lyketsos et al.,
2004).
If the potential MCI participant is able to paraphrase the
information that has been provided and is aware of his/her
rights to refuse or discontinue participation, this will be seen
as indicating capacity to consent. Prior to study participation,
the potential MCI participant must be able to give his/her free
voluntary written informed consent to participate by signing
the Consent Form in the presence of his/her FSP who will
also confirm his/her capacity to decide study participation
and support his/her participation. The FSP will also be asked
to provide his/her written informed consent by signing the
Consent Form. The MCI participant is recommended to
advise his/her GP of his/her decision to participate in this
study.
The recruitment of the MCI participant with his/her FSP is
preferred but not mandatory. The FSP can be a family member,
guardian or person authorized by law, and must be at least
18 years old with no English language difficulties. He/she can
confirm theMCI participant’s capacity for informed consent, and
can provide information about the MCI participant’s functional
abilities, and demographics, health and lifestyle details. The
knowledge of the FSP about the MCI participant is crucial
to corroborate the MCI participant’s capacity for informed
consent and then provide information that could add value
to the data. The FSP is required to be present with the MCI
participant during the first data collection session to witness
the consent process, and is also encouraged to attend the
second and third data collection sessions, and the 8-week
group mindfulness training program together with the MCI
participant.
All MCI participants will be provided with the mindfulness
training program manual and a mindfulness practice disc
containing guided audio recordings to guide and support them
with their home mindfulness practice, and a gift card valued at
$50 to compensate them for travel costs. The FSP is encouraged
to use these resources and practice mindfulness with the MCI
participant as a show of support.
MATERIALS AND METHODS
This study was approved by the Melbourne Health
Human Research Ethics Committee (Project number:
HREC/14/MH/324) and will be carried out in accordance
with the National Statement on Ethical Conduct in Human
Research (2007) to protect the interests of the participants
from whom written informed consent will be obtained. This
study has been registered in the Australian New Zealand
Clinical Trials Registry (ANZCTR) and allocated the ACTRN:
ACTRN12614000820606. All the data and information collected
for, used in, or generated by this study will be securely
stored for 5 years from the date of publication to allow
reference and research discussion after which time it will
be securely disposed of in accordance with the guidelines
required by the Melbourne Health Human Research Ethics
Committee.
Intervention
In addition to the standard care that the MCI participants
obtain from their treating health professionals, they will
receive the mindfulness training intervention. The intervention
will be customized to the needs, health outcomes and
level of understanding of MCI participants with a 1-year
follow-up period. Participation in the 8-week group mindfulness
training program will involve the MCI participants (preferably
accompanied by their FSP) attending a 1.5-h group session, once
weekly for a total period of 8 weeks. The MCI participants’
attendance will be recorded and they are required to attend at
least six of the eight sessions to have satisfactorily completed the
program.
The program intervention will be designed, customized and
facilitated either by a GP Craig Hassed (CH) or a Clinical
Psychologist Richard Chambers (RC) who are experienced
mindfulness experts and Monash University Mindfulness
Consultants. They will be blinded to the identifiable data.
The program includes both formal and informal mindfulness
practices. Participants will be encouraged to practice formal
mindfulness meditation techniques starting with 10 min twice
a day and increasing this time up to 20 min twice a day
as the program progresses. The formal mindfulness practice
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involves using techniques such as “body scan” and “breath”
meditations to observe and maintain attention on an object
of meditation without judgment and reactivity even when
one becomes distracted by drifting thoughts or uncomfortable
emotions. Informal mindfulness practice involves extending
such attentiveness and awareness to engaging daily experiences
such as mindful walking and eating. The informal practice
will also include mental exercises such as reading, puzzles and
language as well as being mindful of daily interactions and
other ADL. Participants will also explore how mindfulness
can help with attention and memory, ADL functioning, stress,
anxiety and depression, emotion management, learning, mental
flexibility and problem solving, and sleep with in-class and
home practices (see Table 1 for a more detailed program
outline).
The MCI participants who could be assisted by their FSP,
will be asked to record on their mindfulness practice record
forms in the program manual, daily entries of their formal
and informal mindfulness practices during the 8-week group
mindfulness training program, and weekly entries during the
1-year follow-up. The MCI participants are requested to submit
their daily practice record forms weekly during the program and
the weekly post-program practice record forms to researcher
(WW) on a monthly basis for effective monitoring of their
mindfulness practice progress over the follow-up period. Weekly
reminders to the MCI participants and/or their FSP will be
done by email or phone during the program duration. After
the program completion, they will receive monthly reminders
by email or phone to follow up with their mindfulness practice
progress. They could also contact the researchers should they
have questions or concerns at any stage.
It is possible that the mindfulness training program and/or
data collection sessions may arouse concerns or anxieties
among the MCI participants or FSPs. As the program is
customized and facilitated by experienced mindfulness experts,
such discomfort is anticipated to be minimal. Measures have
been taken to ensure their well-being throughout their study
participation/involvement. However, if they become upset or
distressed as a result of their participation in the research, they
can approach the researchers or their GP. They will also be
provided with contact details of telephone support services.
If the MCI participant decides to withdraw, his/her GP or
treating health professional will be updated. However, if the FSP
decides to withdraw and the MCI participant chooses to remain
in this study, discussion will be undertaken with both of them
either to find another suitable FSP to continue taking part for
the purpose of the continuity of the data collection and analysis,
or the MCI participant may continue without the FSP if he/she
so wishes. The research team will not collect additional data
and information from withdrawn MCI participants and FSPs,
although with approval, previous data and information already
collected, will be retained to form part of the study results to
ensure proper measurement.
Outcome Measures
This study undertakes a mixed-methods approach involving
the collection and analysis of quantitative data using cognitive
assessments and questionnaires, and of qualitative data collected
through participant observation and semi-structured interviews.
Quantitative Data
The primary outcome is the change in cognitive function
assessed by the Montreal Cognitive Assessment (MoCA) that
measures the MCI participants’ eight cognitive domains of
visuospatial/executive, naming, memory, attention, language,
abstraction, delayed recall, and orientation over time. The
MoCA has excellent sensitivity of 90%, high test-retest reliability,
predictive values, content validity and specificity, and good
internal consistency (Cronbach’s alpha of 0.83; Nasreddine et al.,
2005). The MoCA will be administered by researcher (WW)
during all three data collection sessions.
The secondary outcomes measured will be changes in
psychological health, mindfulness and ADL functioning.
The MCI participants will complete the following self-rated
questionnaires during all three data collection sessions:
a. 21-item Depression Anxiety Stress Scales (DASS-21) that
measures psychological health on the axes of depression,
anxiety and stress on a continuum of severity over the past
week (high internal consistency with respective Cronbach’s
alphas of 0.94, 0.87, and 0.91; Antony et al., 1998); and
b. 14-item Freiburg Mindfulness Inventory (FMI) that measures
the experience of mindfulness within the past 7 days (high
internal consistency with Cronbach’s alpha of 0.86, construct
validity and sensitivity to change; Walach et al., 2006).
In addition, another secondary outcome measure of ADL
functioning will be assessed using the 25-item Bayer Activities
of Daily Living (B-ADL) Scale (Cronbach’s alpha above 0.98)
which will be completed by the FSP who will rate the MCI
participant’s functional deficits in the performance of everyday
activities (Hindmarch et al., 1998; Erzigkeit et al., 2001).
The MCI participants’ adherence of formal and informal
mindfulness practices will be measured using the 12-item
Mindfulness Adherence Questionnaire (MAQ) which was
developed specifically for this study (see Supplementary
Material). This questionnaire that will be administered during
all three data collection sessions, prompts MCI participants to
rate their mindfulness practices over the past week. Further, with
general health and lifestyle factors being potential confounding
factors, information about the MCI participant’s health, physical
and social activity, lifestyle activities, dietary intake, alcohol
consumption, smoking and demographic details will be collected
from the FSP during all three data collection sessions, using
a Demographic, Health and Lifestyle (DHL) questionnaire
that was adapted from the Australian Longitudinal Study on
Women’s Health (The Active Australia Survey, 2003; Brown
et al., 2008; Seventh Survey for the Women of the 1946–51
Cohort, 2013), the Diet Habits Questionnaire (McKellar et al.,
2008) and the Lifestyle Activity Questionnaire (Carlson et al.,
2012) for this study (see Supplementary Material).
In the event of the FSP’s unavailability during the second
and/or third data collection sessions, he/she can return the
completed B-ADL Scales and DHL questionnaires using reply
paid return envelopes provided.
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TABLE 1 | Customized 8-week group-based MCI mindfulness training program outline.
Week 1
• Aims of the program
• Outline the principles and structure of the program, resources and role of Familiar Support Person (FSP)
• Introduction
What mindfulness is and why it can be helpful for MCI
• Importance of mindfulness practice (Formal and Informal approaches)
• In-class mindfulness meditation with guided instructions–e.g., “Body scan” meditation (10min) and Debrief
• In-class informal mindfulness practice with guided instructions–e.g., mindful eating
• “Questions and Answers” session
• Home practice
Formal mindfulness practice (2× 10-min “Body scan” meditation daily)
Informal practice in daily life–e.g., mindful eating
Inquiry: Noticing mindfulness vs. default mode and Effects of each
Week 2
• In-class “Breath” meditation (I) with guided instructions emphasizing curiosity (5min)
• Debrief home practice from the last week
• Discussion about Mindfulness, Attention and Memory (Curiosity and Focus)
• In-class “Breath” meditation (II) with guided instructions emphasizing gentleness (10min)
• Importance of mental exercises
• In-class mental exercises with series of choices–e.g., crossword puzzles, Sudoku, spot the differences etc. and Debrief
• “Comma”
To illustrate that formal practice can be done anytime and anywhere quickly (does not require 10min)
• Home practice
Formal mindfulness practice (2× 10-min “Body scan”/”Breath” meditations daily)
Informal practice in daily life–e.g., mindful eating
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 3
• In-class Mindful listening meditation with guided instructions (5min)
• Debrief home practice from the last week
• Mindfulness and Activities of Daily Living (ADL) functioning (Part I)–e.g., communications, medication management, use of technology and domestic appliances,
cooking, shopping
• In-class mindfulness meditation with guided instructions–“Full stop” (15min)
• In-class mindfulness exercises with guided instructions–e.g., “Music” and “Communicating with awareness” and Debrief
• Home practice
Formal mindfulness practice (2× 15-min “Body scan”/”Breath” meditations daily)
Informal practice in daily life–e.g., mindful eating/communications, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 4
• In-class mindfulness meditation (I) with guided instructions (10min)
• Debrief home practice from the last week
• Mindfulness and Stress, Anxiety, and Depression
The role of default mental activity in mental health problems
The importance of being in the present moment
• In-class mindfulness meditation (II) with guided instructions (15min)
• Home practice
Formal mindfulness practice (2× 15-min “Body scan”/“Breath”/Mindful listening meditations daily)
Noticing stress response, default mode and returning attention to present
Informal practice in daily life–e.g., mindful eating/communications, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 5
• In-class mindfulness meditation with guided instructions (20min)
• Debrief home practice from the last week
• Mindfulness and Emotion management
(Continued)
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TABLE 1 | Continued
• In-class “Working with distractions” experiment with guided instructions and Debrief
• In-class mindfulness exercises with guided instructions–e.g., “Working mindfully with emotions” and “Compassion/Loving-kindness”
• Home practice
Formal mindfulness practice (2× 20-min “Body scan”/“Breath”/“Loving-kindness” meditations daily)
Informal practice in daily life–e.g., mindful eating/communications, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 6
• In-class mindfulness meditation with guided instructions (20min)
• Debrief home practice from the last week
• Mindfulness and Learning, Mental flexibility, and Problem solving
• In-class mindfulness exercises with guided instructions–e.g., “Multi-tasking–Communicating and Problem-solving”
• Written exercises–To acknowledge distractions/note actual thoughts on the second column/writing pad
• Home practice
Formal mindfulness practice (2× 20-min “Body scan”/“Breath”/“Loving-kindness” meditations daily)
Informal practice in daily life–e.g., mindful eating/communications, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 7
• In-class mindfulness meditation with guided instructions (20min)
• Debrief home practice from the last week
• Mindfulness and ADL functioning (Part II)–e.g., financial management, transportation, driving, use of public transport, walking
• In-class mindfulness exercises with guided instructions–e.g., 15min of “Mindful walking”
• Home practice
Formal mindfulness practice (2× 20-min “Body scan”/“Breath”/“Loving-kindness” meditations daily)
Informal practice in daily life–e.g., mindful walking (both as exercise and incidental when traveling)/eating/communications, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Week 8
• In-class mindfulness meditation with guided instructions (20min)
• Debrief home practice from the last week
• Debrief course
Importance of formal mindfulness practice
Importance of incorporating informal mindfulness into day-to-day activities
Mindfulness as a way of life
Mindfulness and MCI/Alzheimer’s disease
• Ongoing home practice
Formal mindfulness practice (2× 20-min “Body scan”/“Breath”/“Loving-kindness” meditations daily)
Informal practice in daily life–e.g., mindful eating/communications/walking, physical exercises
Mental exercises–e.g., reading, puzzles, language (at least 15min daily)
Qualitative Data
Qualitative data collection will involve participant observation of
the 8-week group mindfulness training program and individual
semi-structured interviews conducted separately with the MCI
participant and his/her FSP. The recruitment target of which
qualitative data saturation with no new discoveries is anticipated
to be about 20 MCI participants.
Researcher (WW) will attend all the eight sessions of the
group mindfulness training program to conduct participant
observation in order to evaluate how the MCI participants
and FSPs engage with the program, particularly with the core
modules of “attention and memory,” “ADL functioning,” “stress,
anxiety and depression,” “emotion management,” “learning,
mental flexibility and problem solving,” and to assess the nature
of group interactions between the Mindfulness Trainer and the
MCI participants/FSPs, and amongst the MCI participants/FSPs
during the program. Notes will be recorded during and following
the observation for subsequent qualitative data analysis.
Semi-structured interviews will be conducted by researcher
(WW) during the data collection sessions at post-intervention
(T2) and 1-year follow-up (T3). During each of these two data
collection sessions, separate interviews with the MCI participant
and his/her FSP will be done after the MCI participant has
completed the cognitive assessment and questionnaires/scales.
These interviews aim to elicit responses from individual
perspectives of the MCI participant and his/her FSP in relation
to their own mindfulness training program experience; the
perceived effects of the program and mindfulness practice have
on the health and life of MCI participants and FSPs; the
challenges faced by the MCI participants in implementing and
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maintaining mindfulness practice; and the expectations of the
MCI participants and FSPs about mindfulness practice. The
interview questions for the MCI participant at T2 and T3 are
appended in Table 2; and the separate set of interview questions
for the FSP at T2 and T3 is appended in Table 3. In the event
of the FSP’s unavailability during T2 and/or T3 data collection
sessions, arrangements can be made for the interviews to be
conducted over the phone. All the interviews will be recorded
on a digital audio recorder to ensure accurate representation of
responses, and transcribed verbatim by researcher (WW).
STEPWISE PROCEDURES
Altogether, there are a total of 3 data collection sessions in
this study, which will be held at any of the Monash University
campuses or a public venue such as library and community club
that is convenient to the MCI participant and his/her FSP. The
MCI participant will be administered the MoCA, the 21-item
DASS-21, the 14-item FMI and the 12-item MAQ by researcher
(WW) during these data collection sessions at three time points:
a. Pre-intervention (T1);
b. Post-intervention (T2); and
c. One-year follow-up (T3).
These measurements should take about 30 min each session
and will be conducted to compare the effects of mindfulness
on the outcomes measures across these time frames and to
determine whether any changes are sustained over time. By
incorporating a 1-year follow-up into the study design, it could
more effectively measure the longitudinal effects of mindfulness
practice on persons with MCI over time. A semi-structured
interview with the MCI participant that should take about 30
min, will be conducted by researcher (WW) at T2 and T3 after
he/she has completed the above-mentioned cognitive assessment
and questionnaires/scales.
The nature of the participants’ MCI condition could possibly
fluctuate between the time frames of provision of written
informed consent (with their capacity to consent as confirmed
by their FSP) and the 1-year follow-up period. In other words,
their MCI condition could remain stable, improve or deteriorate
to AD during the study duration. In the event that the MCI
participant’s MoCA score suggests severe cognitive impairment,
his/her continued study participation will be reviewed and the
referral to his/her GP or treating health professional for follow-up
will be discussed with him/her and his/her FSP. Likewise, if
the MCI participant reports a clinically significant DASS-21
score, the research team will contact him/her to ensure his/her
well-being and seek his/her permission to inform his/her FSP and
forward the score to his/her GP or treating health professional
for follow-up. Any clinically significant information about the
MCI participants collected from their study participation, will be
stored in their health records with the participating CDAMS sites
or communicated to their GP or treating health professional.
While the administration of the cognitive assessment and
questionnaires/scales is in progress with the MCI participant
during each of the three data collection sessions, the FSP will
provide information about the MCI participant by completing
the B-ADL Scale and the DHL questionnaire on his/her own.
During T2 and T3, the FSP will be asked to attend a semi-
structured interview that will take up to 30min after the interview
session with the MCI participant is completed. In sum, the
FSP’s study involvement duration during T1 is about 30 min,
and during T2 and T3 is about an hour each. Should the FSP
be unavailable to attend T2 and/or T3, he/she can return the
completed B-ADL Scales and DHL questionnaires using reply
paid return envelopes provided, and arrangements can be made
for the interviews with the FSP to be conducted over the phone.
For an overview of this study, the stages of the study protocol
are illustrated in Figure 1.
ANTICIPATED RESULTS
Repeated measures analysis of variance will be used to
test the relative effects of formal and informal mindfulness
practices on changes in the following dependent variables,
namely cognitive function, psychological health, mindfulness,
and ADL functioning from pre- to post-intervention and from
post-intervention to 1-year follow-up, with an experiment-wise
error rate of 0.05. Normally, each ANOVA should be evaluated
with an adjusted (for e.g., Bonferroni correction) decision-wise
error rate for possible inflation of Type I error. However, Type I
error rate will not be adjusted for these analyses, on the grounds
that this is an exploratory study of which any possible effects
should be examined by further research. Regression analysis will
be used to determine the predictive values of measures of formal
and informal mindfulness practices on the changes in the same
dependent variables (cognitive function, psychological health,
mindfulness, and ADL functioning). Age, gender, and education
will be entered into the regression analysis to identify possible
moderating effects. The MCI participants’ demographics, health
and lifestyle information will be examined in relation to the
outcome measures in order to interpret the results in context.
However, possible trends instead of statistically significant results
could be determined from the quantitative analysis. As such,
the mixed-methods design of this study enables the qualitative
findings to complement the quantitative results in greater depth
so that their findings could inform each other and be integrated to
better address the research questions. The IBM Statistical Package
for the Social Sciences software package will be used for the
statistical analysis of the quantitative data.
Qualitative data analyses by researchers (WW) and Jan Coles
(JC) will entail the investigation of the participant observational
field notes and the semi-structured interview transcripts. To
safeguard privacy, any identifiable information such as the
name of the MCI participant, FSP, CDAMS, health service, GP
and treating health professional in the audio recording of the
interviews will be coded (but re-identifiable by the researchers for
qualitative data analyses) in the interview transcripts. The QSR
International NVivo software will be used to perform thematic
analyses for the identification of important patterns/themes.
The iterative (repeating) and inductive (bottom up) process
of thematic analysis in the qualitative data analysis phase
Frontiers in Aging Neuroscience | www.frontiersin.org 9 June 2016 | Volume 8 | Article 156
Wong et al. Mindfulness and Mild Cognitive Impairment
TABLE 2 | The interview questions for the MCI participants at post-intervention (T2) and 1-year follow-up (T3).
Qn Post-intervention (T2)–30 min 1-year follow-up (T3)–30 min
1 Can you please describe your general health for me?
I really appreciate you sharing your views.
2 Can you tell me as much as possible how has the mindfulness training program
experience been for you?
[Interviewer’s prompts: satisfactory? stimulating? useful?]
3 What did you like or enjoy about the program?
What did you not like about the program?
From your perspective, how can we improve the mindfulness training program
experience for future participants?
4 Can you please tell me how you practice mindfulness?
How do you use mindfulness in your day-to-day life?
5 Can you please tell me what has helped or hindered your mindfulness practice?
6 Can you please tell me in as much detail as possible how you have been since practicing mindfulness?
[Interviewer’s prompts: cognitive function, psychological health, functional abilities and quality of life]
7 From your perspective, how did your mindfulness practice influence your health and life?
[Interviewer’s prompts: cognitive function, psychological health, functional abilities and quality of life]
8 Do you think you would continue to practice mindfulness?
How long would you continue?
9 Do you need any ongoing support and reminders to maintain regular
mindfulness practices after the program?
Do you need any ongoing support and reminders to continue
regular mindfulness practices from now on?
If yes, what kind of ongoing support and reminders? If yes, what kind of ongoing support and reminders?
10 What advice would you give to other people like yourself about undertaking
mindfulness training?
What advice would you give to other people like yourself
about practicing mindfulness?
11 Can you please describe the role of your familiar support person in the
mindfulness training program and outside the program?
Can you please describe the role of your familiar support
person for the past year after the mindfulness training
program?
12 Any questions or comments you would like to make?
breaks the data into “smaller chunks” and assigns names
or “codes” that summarize the idea within the data chunk
(Hansen, 2006; Liamputtong, 2013). The codes are then refined
by comparing, sorting and reflecting on the meaning and
subsequently developed into “themes”1. A coding framework will
be developed to provide definitions of the codes and maximize
coherence among the codes for coding the qualitative data and
generating themes or categories (Creswell, 2014). For inter-coder
reliability, codes developed by researchers (WW and JC) will
be cross-checked for agreement in coding with the same or
similar code in order tomaintain consistency in coding (Creswell,
2014). The framework of the presentation of both qualitative and
quantitative data is illustrated in Figure 2.
The MCI participants and FSPs have the option to receive
an email containing a summary of the non-identifiable group
1(2006). 10 questions to help you make sense of qualitative research. England:
Public Health Resource Unit.
results when this study is completed. The findings from this
study will be disseminated through peer-reviewed academic
journal publications and presented at national and international
seminars and conferences. In any publication and presentation,
the information will be presented in non-identifiable
form to protect the privacy of the MCI participants and
their FSP.
It is expected that the mindfulness training intervention will
proactively engage the MCI participants early and yield the
practical application of improving their cognitive function such
as attention and memory if they maintain mindfulness practice
over time. There may be a potential benefit of delaying the
progression of MCI to AD but this will not be assessed in this
study. In addition, other expected improvements in psychological
health, mindfulness, and in functional abilities of ADL may also
indicate better health outcomes of mindfulness for MCI. This
study will contribute toward the clinical research of MCI and
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TABLE 3 | The interview questions for the Familiar Support Persons (FSPs) at post-intervention (T2) and 1-year follow-up (T3).
Qn Post-intervention (T2)–30 min 1-year follow-up (T3)–20 min
1 What has it been like supporting (first name of the MCI participant)?
I really appreciate you sharing your views.
2 From your personal perspective, how has the mindfulness training program
experience been for you?
How about your perspective on the program experience as a familiar support
person?
3 Can you please describe how has attending the program influenced you
personally?
How has mindfulness influenced you in the past year?
4 How can we improve the mindfulness training program experience for future
familiar support persons?
5 Can you please describe how (first name of the MCI participant) has practiced
mindfulness?
Can you please describe how (first name of the MCI participant) has
practiced mindfulness in the past year?
How do you think (first name of the MCI participant) has used mindfulness in
his/her day-to-day life?
How do you think (first name of the MCI participant) has used
mindfulness in his/her day-to-day life?
6 From your perspective, how has mindfulness influenced (first name of the MCI
participant)’s health and life?
From your perspective, how has mindfulness influenced (first name of
the MCI participant)’s health and life in the past year?
How useful do you think mindfulness has been for him/her? How useful do you think mindfulness has been for him/her overall?
[Interviewer’s prompts: cognitive function, psychological health, functional
abilities & quality of life]
[Interviewer’s prompts: cognitive function, psychological health,
functional abilities and quality of life]
7 What do you think about your role in supporting (first name of the MCI
participant) in mindfulness practice during and outside the program?
What do you think about your role in supporting (first name of the MCI
participant) in mindfulness practice in the past year?
8 Any questions or comments you would like to make?
FIGURE 1 | Stages of study protocol. Abbreviations (in alphabetical order): B-ADL, Bayer Activities of Daily Living (25-item); DASS 21, Depression Anxiety Stress
Scales (21-item); DHL, Demographic, Health and Lifestyle questionnaire; FMI, Freiburg Mindfulness Inventory (14-item); MAQ, Mindfulness Adherence Questionnaire
(12-item); MCI, Mild Cognitive Impairment; MoCA, Montreal Cognitive Assessment.
advance evidence-based knowledge about the effects of long-
term mindfulness practice as a promising and feasible non-
pharmacological therapeutic approach for persons with MCI.
This could potentially translate to downstream significance of
better quality of life and higher work productivity of persons
with MCI and their FSP, and a reduced chronic disease burden
on families of persons with MCI and the healthcare system.
If effective, “partnerships could be eventually forged with the
Alzheimer’s Australia and memory clinics/services such as the
CDAMS to deliver the customized group mindfulness training
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FIGURE 2 | Framework of the presentation of qualitative and quantitative data. ADl, Activities of Daily Living; ANOVA, Analysis of variance; FSP, Familiar
Support Person; MCI, Mild Cognitive Impairment.
program to the target population of persons with MCI and their
FSP” (Wong et al., 2015).
The study findings could open a potential future research
direction to explore the use of biomarkers such as beta-
amyloid and tau proteins to monitor the longitudinal effects of
mindfulness practice on the cognitive and functional progression
of persons with MCI and the conversion rate from MCI to AD.
POTENTIAL PITFALLS AND
COUNTERACTING MEASURES
This study was originally designed as a randomized controlled
trial using pre- and post-intervention design that will assign
persons who have been clinically diagnosed with MCI to either
the 8-week mindfulness training intervention group or the
“standard care” control group. In the original randomized
controlled trial design, the estimated total sample size is 166–83
MCI participants in the intervention group and 83 in the
control group, in order to achieve 80% power for a two-
tailed test at the alpha level of 0.05 with a medium effect
size of 0.50. The minimum sample size required to detect a
clinically significant difference is 68 participants–34 in each of
the two groups. This design was approved by the Melbourne
Health Human Research Ethics Committee. However, due to
the challenges in the study recruitment of MCI participants,
changes had to be made to the randomized controlled trial study
design to that of a pilot study that would explore the feasibility
of the mindfulness training intervention for future research.
Consequently, the revised target sample size is about 20 MCI
participants. An estimation of 80 interviews conducted with 20
MCI participants and 20 FSPs at T1 and T2, and coupled with
participant observation of the mindfulness program produce rich
qualitative data and provide important participant perspectives
such as learning and maintaining a new behavior, that could
yield significant contributions to the field (Morse, 2000; Creswell,
2007), especially in this sub-clinical population that is under
explored. The findings would be relevant to better understand
this population, help future study recruitment, and shed insights
to further research studies with this population. This revised
study design was also approved by theMelbourne Health Human
Research Ethics Committee.
As the age profile of the MCI participants is senior (at least
60 years old), program attendance and participation might be
affected by various circumstances such as clinically significant
scores of cognitive impairment measured by MoCA and of
psychological health measured by DASS-21, conversion to
dementia such as Alzheimer’s disease, and pre-existing medical
conditions. The research team will review the participants’
continued study participation and notify their GP or treating
health professional for follow-up after discussion with them.
The MCI participants are required to attend at least six of the
eight sessions to have satisfactorily completed the mindfulness
training program. The MCI participants and FSPs are provided
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with the program manual and the mindfulness practice audio
CD, and researcher (WW) contacts the MCI participants weekly
during the program duration to discuss any questions, concerns
and issues that they might have. WWwill also inform the outline
of the weekly module to those who have missed the session.
To encourage the MCI participants to do their mindfulness
practices and obtain their monthly practice record forms,
researcher (WW) will contact them on a monthly basis after their
completion of the mindfulness training program. However, due
to the extent of cognitive impairment of certainMCI participants,
particularly for those who are not living with their FSP, WW
might have to contact them more frequently to better support
them. Such study rigor might impose some inconvenience on
these MCI participants. Thus, WWwill check with them on their
comfortable frequency of post-intervention communications
such as fortnightly phone calls.
The MCI participants and FSPs are free to withdraw consent
from the study at any stage by informing the research team
which will still include the previous data and information that
are already collected from them in the data analyses to form part
of the study findings.
While the study findings from this reasonably homogeneous
sample may be potentially positive, however, due to the small
sample size, it is not likely to reach statistical significance. As
such, the study will also share the similar study limitation of
small sample sizes in previous studies and its results may not be
generalizable to the broader community.
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